首页> 外文期刊>BMC Ophthalmology >Multiple phototherapeutic keratectomy treatments in a Chinese pedigree with corneal dystrophy and an R124L mutation: a 20-year observational study
【24h】

Multiple phototherapeutic keratectomy treatments in a Chinese pedigree with corneal dystrophy and an R124L mutation: a 20-year observational study

机译:中国谱系角膜营养不良和R124L突变的多次光疗性角膜切除术治疗:一项为期20年的观察性研究

获取原文
获取外文期刊封面目录资料

摘要

To investigate the efficacy and safety of repeated phototherapeutic keratectomies (PTKs) during long-term treatment for corneal dystrophy (CD) in a Chinese pedigree carrying the R124L mutation in TGFBI. This was a retrospective review of 20-year medical and genetic records involving five CD patients (10 eyes) from one pedigree. During this period, PTK was conducted for an eye when best-corrected distance visual acuity (BCDVA) reached ?1.0 (LogMAR), due to either primary or recurrent opacities in the cornea. All PTKs were performed by 193-nm excimer laser with or without creation of epithelial flaps. For each eye, routine measurements were conducted for the number of PTKs during follow-up, mean time to recurrence, and BCDVA pre- and post- every PTK (measurements within 3?months from each PTK). Corneal thicknesses measured after the last PTK and at the last visit were analyzed, and subjective satisfaction was assessed. Gene testing revealed an R124L mutation in TGFBI. During 19.60?±?1.78?years of follow-up, PTKs were conducted twice for three eyes, three times for six eyes, and four times for one eye. After each PTK, effective visual acuity was maintained for 3.60?±?1.12?years before significant recurrence. BCDVA improved significantly postoperatively than preoperatively for the first PTK for each eye (p??0.001), as well as the second (p??0.001) and third one (p??0.001). After the last PTK and at the final visit, the thinnest corneal thickness was 371.50?±?56.47?μm and 358.40?±?101.11?μm, respectively. The average subjective satisfaction score was 8.60?±?0.89. Multiple repeated PTKs were effective and safe in a long-term study of CD patients with an R124L mutation in TGFBI.
机译:目的研究在长期携带角膜营养不良(CD)的中国谱系中进行TGFBI R124L突变的长期光疗性角膜切开术(PTK)的疗效和安全性。这是对一个谱系中五名CD患者(10眼)的20年医学和遗传记录的回顾性回顾。在此期间,由于角膜原发性或复发性混浊,当最佳矫正远视力(BCDVA)≥1.0(LogMAR)时,对眼睛进行PTK。所有PTK均通过193 nm准分子激光进行,有无上皮瓣形成。对于每只眼睛,在随访期间对PTK的数量,平均复发时间以及每个PTK前后的BCDVA进行常规测量(从每个PTK开始的3个月内进行测量)。分析在最后一次PTK之后和最后一次就诊时测得的角膜厚度,并评估主观满意度。基因测试显示TGFBI中存在R124L突变。在随访的19.60±1.78年内,对三只眼进行了两次PTK,对六只眼进行了三遍,对一只眼进行了四次。每次PTK后,有效视力维持3.60±1。12年。相对于术前,每只眼睛的第一只PTK(b <0.001),第二只(p <0.001)和第三只(p <0.001),BCDVA均显着改善。在最后一次PTK之后和最后一次访视时,最薄的角膜厚度分别为371.50±±56.47μm和358.40±±101.11μm。平均主观满意度得分为8.60±0.89。在对TGFBI中具有R124L突变的CD患者的长期研究中,多次重复的PTK有效而安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号